Medtronic (MDT) Raises Quarterly Dividend 7.9% to $0.68; 2.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities
May 27, 2022 8:09 AM EDTTruist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.
The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More
Medtronic, Inc. (MDT) PT Lowered to $117 at Cowen; FY23 Can Be a Year of Real Pipeline Progress
May 27, 2022 6:21 AM EDTCowen analyst Joshua Jennings lowered the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $125.00) while maintaining an Outperform rating following earnings. Despite weak guidance, the analyst said FY23 can be a year of real pipeline progress.
The analyst commented, "MDT delivered... More
Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel
May 27, 2022 6:13 AM EDTStifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $125.00 (from $128.00) while maintaining a Buy rating.
The analyst commented, "Yes. We had hoped that Medtronics F4Q22 (Apr.) would show more visibly-positive signs of CEO Geoff Marthas positive... More
